Aims: Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TILs) has demonstrated benefit for patients with advanced melanoma refractory to first-line immune checkpoint inhibitors (ICIs).…

Read more about 'Elevated emotional distress before tumor-infiltrating lymphocytes therapy is associated with reduced therapeutic outcomes'...

Posted in Research; Posted 59 days ago 2 Minute(s) to read

Gut microbiota has been associated with carcinogenesis and immune regulation. While there is evidence supporting its influence on immunotherapy response in melanoma, its impact on BRAF/MEK-targeted th…

Read more about 'Specific gut microbial taxa and immune-related gene expression patterns may be associated with differential responses to BRAF/MEK-targeted therapy in metastatic melanoma'...

Posted in Research; Posted 59 days ago 1 Minute(s) to read